Deutsche Bank
BNR

Deutsche Bank’s Burning Rock Biotech BNR Stock Holding History

Deutsche Bank’s Portfolio BNR Stock Details BNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-214
Closed -$20K – 4200
2021
Q4 		$20K Sell
214
-6,660
-97% -$912K ﹤0.01% 4124
2021
Q3 		$1.23M Buy
6,874
+253
+4% +$56.2K ﹤0.01% 2482
2021
Q2 		$1.95M Buy
+6,621
New +$1.96M ﹤0.01% 2248

Other funds holding BNR

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Deutsche Bank's BNR Position: Q1 2022 in Review

Deutsche Bank sold out of Burning Rock Biotech (BNR) in Q1 2022, closing a stake of 214 shares — an estimated $20K sold.

Deutsche Bank first reported a position in BNR in Q2 2021 and held it in 3 quarters. The position peaked at $1.95M in Q2 2021. 46 funds tracked by Wall St. Rank hold BNR as of Q1 2022.

  • Deutsche Bank reported no remaining Burning Rock Biotech position as of Q1 2022 after selling out during the quarter.
  • Deutsche Bank sold 214 Burning Rock Biotech shares in Q1 2022, an estimated $20K.
  • Deutsche Bank first reported a position in Burning Rock Biotech in Q2 2021 and held it in 3 quarters.
  • Deutsche Bank's Burning Rock Biotech position peaked at $1.95M in Q2 2021.
  • 46 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q1 2022.

Based on Deutsche Bank's 13F filing for Q1 2022, filed 13 May 2022.